The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...

Following his inauguration as President of Nigeria in May 2023, Bola Tinubu announced in his inaugural address that his ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private, all seven independent members of its ...

Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

High-dose vitamin D added to chemotherapy failed to provide a benefit in patients with metastatic colorectal cancer in the ...

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...

It is believed about 200 roles will be cut at the facility in Barnard Castle, County Durham, in October 2025. The team ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

This Comment is linked to The Lancet Haematology Series on Sexual Health in Patients with Haematological Malignancies; we ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...